DEUTSCHE BANK AG\
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in REGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$483,199,777
-$106,451,778 QoQ
Shares Held
625,388
-18.1% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 25.671583081223176.ToString("F0")%
Shared 0.ToString("F0")%
None 74.32841691877682.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. REGN ranks #2 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $483,199,777 | 625,388 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $589,651,555 | 763,926 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $391,722,818 | 696,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $373,189,425 | 710,837 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $344,445,232 | 543,092 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $384,137,478 | 539,269 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $465,636,238 | 442,940 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $421,643,799 | 401,172 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $300,370,023 | 312,076 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $285,791,166 | 325,395 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $223,541,441 | 271,631 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $215,404,632 | 299,781 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $248,762,230 | 302,752 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $233,790,171 | 324,038 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $224,057,716 | 325,254 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $214,476,143 | 362,824 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $287,752,523 | 412,005 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $262,043,530 | 414,941 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $271,700,393 | 448,958 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $280,225,654 | 501,711 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $219,660,915 | 464,262 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $207,626,658 | 429,771 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $210,957,004 | 376,857 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $225,462,565 | 361,521 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $191,076,660 | 391,318 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||